Hudson Bay Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Hudson Bay Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-46,900	Closed	-$5.15M	–	791
2018 Q2	$5.15M	Buy	+46,900	New	+$5.02M	0.07%	269
2016 Q3	–	Sell	-12,000	Closed	-$1.03M	–	471
2016 Q2	$1.03M	Buy	+12,000	New	+$1.08M	0.03%	245
2016 Q1	–	Sell	-10,896	Closed	-$1.23M	–	206
2015 Q4	$1.23M	Buy	+10,896	New	+$1.18M	0.07%	131

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Hudson Bay Capital Management's IBB Position: Q3 2018 in Review

Hudson Bay Capital Management sold out of iShares Biotechnology ETF (IBB) in Q3 2018, closing a stake of 46,900 shares — an estimated $5.15M sold.

Hudson Bay Capital Management first reported a position in IBB in Q4 2015 and held it in 3 quarters. The position peaked at $5.15M in Q2 2018. 630 funds tracked by Wall St. Rank hold IBB as of Q3 2018.

Hudson Bay Capital Management reported no remaining iShares Biotechnology ETF position as of Q3 2018 after selling out during the quarter.
Hudson Bay Capital Management sold 46,900 iShares Biotechnology ETF shares in Q3 2018, an estimated $5.15M.
Hudson Bay Capital Management first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 3 quarters.
Hudson Bay Capital Management's iShares Biotechnology ETF position peaked at $5.15M in Q2 2018.
630 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2018.

Based on Hudson Bay Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.